Animas Corporation Market Share Analysis

Animas Corporation Market Share Analysis

Summary

Our new report, “Animas Corporation Market Share Analysis” provides in-depth information on Animas Corporation’s market position in the different medical equipment markets it operates in. The report provides Animas Corporation market share information in one key market category – Insulin Delivery Devices. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Scope

- Global company shares (in Revenues) information for the key markets Animas Corporation operates in – Diabetes Care Devices.
- Animas Corporation’s company shares (in Revenues) information for all the key countries the company has presence in – China, Australia, Germany, United Kingdom, France, Italy, Spain, Canada, United States and Brazil.
- Animas Corporation’s company shares (in Revenues) information for all the key market category the company has presence in – Insulin Delivery Devices.
- All the key data-points are for 2011 and cover all the key regions – Europe, North America, Asia-Pacific, South and Central America and Middle East and Africa.
- Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries.

Reasons to buy

- Develop sales and marketing strategies by identifying who-stands-where in the markets, Animas Corporation operates in.
- Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to Animas Corporation’s market positions. SHOW LESS READ MORE >

1
1

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of Markets/Categories Covered
3.1 Diabetes Care Devices
3.1.1 Insulin Delivery
4 Company Snapshot
4.1 Key Information
4.2 Company Overview
4.3 Major Products and Services
4.3.1 Overview
5 Competitors
6 Competitive Landscape
6.1 Diabetes Care Devices (Insulin Delivery), Global, Market Share (%), 2011
6.2 Animas Corporation, Diabetes Care Devices(Insulin Delivery), by Region, Market Share (2011)
6.3 Animas Corporation, Diabetes Care Devices(Insulin Delivery), by Country, Market Share (2011)
7 Key Employees
8 Locations And Subsidiaries
8.1 Head Office
9 Financial Deals Landscape
9.1 Animas Corporation, Deals Volume Summary, 2006 to YTD 2012
10 Animas Corporation Detailed Deal Summary
10.1 Partnerships
10.1.1 DexCom Amends Agreement With Animas
10.1.2 DexCom Enters Into A Joint Venture With Animas
10.2 Acquisition
10.2.1 Johnson & Johnson Acquires Animas
11 Recent Developments
11.1 Strategy And Business Planning
11.1.1 Jan 13, 2010: JDRF Forms Partnership With Animas To Develop First-Generation Automated System For Managing Type 1 Diabetes
11.2 Product News
11.2.1 Jan 13, 2010: Animas To Co-Develop First-Generation Automated System For Managing Type 1 Diabetes With JDRF
11.2.2 Jul 15, 2009: Animas Corporation Receives Health Canada Approval For OneTouch Ping Glucose Management System
11.2.3 Jul 01, 2008: Animas Corporation's OneTouch Ping Glucose Management System Cleared By FDA
11.3 Product Approvals
11.3.1 Jul 15, 2009: Animas Corporation Receives Health Canada Approval For OneTouch Ping Glucose Management System
11.3.2 Jul 01, 2008: Animas Corporation's OneTouch Ping Glucose Management System Cleared By FDA
12 Appendix
12.1 Research Methodology
12.2 Secondary Research
12.3 Primary Research
12.4 Models
12.5 Forecasts
12.6 Expert Panels
12.7 Consulting
12.8 Currency Conversion
12.9 Contact Us
12.10 Disclaimer

1.1 List of Tables
Table 1: Animas Corporation, Key Facts, 2011
Table 2: Diabetes Care Devices (Insulin Delivery), Global, Company Share by Revenue ($m), 2011
Table 3: Animas Corporation, Diabetes Care Devices (Insulin Delivery), by Region, Revenue ($m) and Market Share (%), 2011
Table 4: Animas Corporation, Diabetes Care Devices (Insulin Delivery), by Country, Revenue ($m) and Market Share (%), 2011
Table 5: Animas Corporation, Key Employees
Table 6: Animas Corporation, Deals Volume Summary, 2006 to YTD 2012
Table 7: Animas Corporation, Deals Summary, 2006 to YTD 2012
Table 8: DexCom Amends Agreement With Animas
Table 9: DexCom Enters Into A Joint Venture With Animas
Table 10: Johnson & Johnson Acquires Animas
Table 11: USD to Local Currency, Average Exchange Rate, 2011

1.2 List of Figures
Figure 1: Diabetes Care Devices (Insulin Delivery), Global, Market Share (%), 2011
Figure 2: Animas Corporation, Diabetes Care Devices (Insulin Delivery), by Region, Market Share (%), 2011
Figure 3: Animas Corporation, Diabetes Care Devices (Insulin Delivery), by Country, Market Share (%), 2011
Figure 4: Animas Corporation, Deals Volume Summary, 2006 to YTD 2012

Novo Nordisk A/S
Sanofi
Eli Lilly and Company
Medtronic, Inc.
Becton, Dickinson and Company
F. Hoffmann-La Roche Ltd.
Insulet Corporation
Abbott Laboratories
Ypsomed Holding AG
B. Braun Melsungen AG
Terumo Corporation
Hindustan Syringes & Medical Devices